Home  >  Health Check  >  Ebola drug trials in the Democratic Republic of Congo
Health Check
Ebola drug trials in the Democratic Republic of Congo
Health Check
Jul 1, 2026

Two Ebola drugs are due to be trialled in the Democratic Republic of Congo (DRC) as cases of the disease continue to rise in the country.

BBC health and science correspondent James Gallagher joins Claudia Hammond to discuss the new clinical trial, and to update on the latest from the outbreak in the DRC and Uganda.

Claudia also visits The Royal Society’s annual Summer Science Exhibition in London to explore a range of new health research on display.

We hear about how salt water is being used to try to make lateral flow tests more sensitive and targeted, with Guido Bolognesi and Nguyen Thi Kim Thanh from University College London. They also explain the role gold nanoparticles play in current lateral flow tests, which rapidly diagnose pregnancy or Covid-19.

Claudia also visits a 'microbe zoo' and speaks with Revathy Krishnamurthy from the Quadram Institute of Bioscience in Norwich, England, who explains what phages are, and how they can be harnessed to improve food safety.

Finally, we meet Pat Price, visiting professor at Imperial College London, to learn about the high-energy particles that could kill cancer cells, how they could completely change treatment for patients, and how it’s hoped lasers can help them accomplish it.

Image Credit: Credit: Photo by DIEUDONNE DIROLE/EPA/Shutterstock

Presenter: Claudia Hammond Producer: Dan Welsh and Georgia Christie

More Episodes
Jun 24, 2026
Lack of evidence most IVF ‘add-ons’ improve fertility

Many people with infertility use in vitro fertilisation (IVF), however the probability of having a baby following IVF is only approximately 30-40% per cycle and decreases significantly with age. It can be a lengthy and expensive process. Providers sometimes offer ‘add-ons’, additional treatments that they claim could help patients conceive, which are themselves also usually expensive. In Australia, New Zealand and the United Kingdom more than 70% of patients pay for at least one of these add-ons. A new review published in The Lancet Obstetrics, Gynaecology, & Women’s Health journal has found that evidence on the benefits of these add-on treatments is unclear. Claudia Hammond speaks to Dr Sarah Lensen, Senior Research Fellow in the Department of Obstetrics, Gynaecology and Newborn Health at the University of Melbourne.

Joining Claudia from Ghana is genito-urinary consultant and HIV expert, Vanessa Apea. Claudia and Vanessa discuss a draft African Charter on Family, Sovereignty and Values, which claims that comprehensive sex education, as well as a range of sexual and reproductive health rights, are a threat to African families from foreign ideologies.

They also discuss a report from the Office of Inspector General of US Agency for International Development (USAID) which reveals that President Donald Trump’s administration has spent hundreds of thousands of dollars in storage and transportation costs for $9.7 million worth of contraceptives that are being stored in Belgium rather than distributed to the various low-income countries they were intended for. Many of the withheld contraceptives are now expired or unusable due to their removal from temperature-controlled storage.

We also hear from Health Check reporter Jane Chambers in the Chilean city of Valdivia, where wetlands are part of everyday life—and increasingly, part of people’s health. And we hear how faecal-microbiome transplants could improve the efficacy of some antidepressants in patients with major depressive disorder.

Presenter: Claudia Hammond Producers: Jonathan Blackwell & Georgia Christie


26min 29sec



Ebola drug trials in the Democratic Republic of Congo

--:--
--:--